Skip to main content
HR 5587 116th Congress House Health Administrative law and regulatory procedures Congressional oversight Drug safety, medical device, and laboratory regulation Drug trafficking and controlled substances Drug, alcohol, tobacco use Food supply, safety, and labeling Government studies and investigations State and local government operations

To amend the Federal Food, Drug, and Cosmetic Act with respect to the regulation of hemp-derived cannabidiol and hemp-derived cannabidiol containing substances.

Introduced: January 13, 2020 See on congress.gov
Sign in to write a letter Sign in to watch
This bill died when the 116th Congress ended
It never became law before the 116th Congress (2019–2020) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jan 23, 2020
Referred to the Subcommittee on Biotechnology, Horticulture, and Research.
Jan 13, 2020
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Agriculture, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Jan 13, 2020
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Plain-English summary Congressional Research Service

This bill requires the Food and Drug Administration to regulate a hemp-derived cannabidiol (CBD) product as a dietary supplement instead of as a drug. The bill also allows the introduction into interstate commerce of a food with added hemp-derived CBD.

The Department of Agriculture must report on market and regulatory barriers for producers operating under its domestic hemp production program.

What's happening now January 23, 2020

Referred to the Subcommittee on Biotechnology, Horticulture, and Research.

 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 3
 Cosponsors 7
All 7 Democratic 3 Republican 3
KIND, RON
· May 8, 2020
 R
Grothman, Glenn
Wisconsin · Mar 5, 2020
 D
Carbajal, Salud O.
California · Feb 4, 2020
 D
Pocan, Mark
Wisconsin · Feb 3, 2020
 R
Comer, James
Kentucky · Jan 13, 2020
 R
Massie, Thomas
Kentucky · Jan 13, 2020
 D
Pingree, Chellie
Maine · Jan 13, 2020
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 5587: To amend the Federal Food, Drug, and Cosmetic Act with respect to the regulation of hemp-derived cannabidiol and hemp-derived cannabidiol containing substances.. 116th Congress. Open America. https://openamerica.io/bill/116-HR-5587/
MLA
"H.R. 5587: To amend the Federal Food, Drug, and Cosmetic Act with respect to the regulation of hemp-derived cannabidiol and hemp-derived cannabidiol containing substances.." 116th Congress, 2026, Open America, https://openamerica.io/bill/116-HR-5587/.
Bluebook (legal)
H.R. 5587, 116th Cong. (2026), https://openamerica.io/bill/116-HR-5587/.
Markdown link
[H.R. 5587: To amend the Federal Food, Drug, and Cosmetic Act with respect to the regulation of hemp-derived cannabidiol and hemp-derived cannabidiol containing substances.](https://openamerica.io/bill/116-HR-5587/)
Report a problem